Pacifico Biolabs, a Berlin-based mycelium-fermentation protein firm, has closed a €7 million Sequence A funding spherical to scale manufacturing to 200 tonnes per 30 days and to assist industrial launches throughout DACH and Nordic Europe, with manufacturing anchored in Saxony, Germany.
The spherical was backed by Stray Canine Capital, TGFS, Sprout & About Ventures, Simon Capital, FoodLabs, and a regional brewery companion.
Andres Manzanares, Principal at Stray Canine Capital, states, “After a decade backing various protein firms, we see Pacifico as a transparent chief in overcoming the bottlenecks which have held again the class. Through the use of present infrastructure to supply clean-label, nutritious, and reasonably priced meat options which can be indistinguishable from their animal counterparts, Pacifico gives a reputable resolution to a damaged protein provide chain.”
Based in 2022 by Zac Austin and Washington Logroño, Pacifico Biolabs grows meat utilizing its mycelium fermentation biotechnology.
In response to the corporate, various proteins have lengthy struggled to compete on three fronts concurrently: value, texture, and diet. Pacifico claims its fermented mycelium addresses all three. It has a pure meat-like construction and impartial flavour, making it a sensible ingredient for meals producers, lowering the necessity for components and offering a strong basis for personal label merchandise.
Pacifico additionally factors out that attaining value parity with conventional meat has been the important thing lacking factor for various proteins. The corporate states that it’s focusing on value parity from day one by working manufacturing by way of present brewery infrastructure.
Its fermentation course of runs straight in commonplace beer brewery tanks, eradicating the necessity for purpose-built bioreactors and multimillion-euro expenditure. As beer and alcohol consumption lower throughout Europe, many breweries have idle fermentation tanks. Pacifico sees this as a possibility, avoiding the prolonged means of setting up new services and establishing a fast, cost-effective option to scale up manufacturing for mass markets.
“We aren’t simply constructing a meals ingredient firm, we’re placing European industrial infrastructure to work for the way forward for meals. German brewing heritage meets trendy industrial biotechnology. We’re utilizing the {hardware} of the previous to energy the diet of the longer term,” mentioned Zac Austin, co-founder and CEO of Pacifico Biolabs.
The corporate emphasises its function in supporting European protein sovereignty by producing high-quality protein domestically, near the place it’s consumed, utilizing present regional industrial capability.
Sören Schuster (TGFS) commented, “Pacifico solves the business’s scaling drawback with a chic, asset-light mannequin. The mixture of European sovereignty and excessive capital effectivity makes them a key participant within the rising bio-economy. Saxony gives the proper ecosystem of expert labour and industrial spine to anchor this transition.”
With extra funding obtained, Pacifico plans to develop its Leipzig workforce and velocity up its preliminary industrial partnerships. The merchandise are anticipated to be obtainable on retail cabinets by way of model and retailer companions by late 2026.
